PSEUDOVITELLIFORM MACULOPATHY SECONDARY TO BRAF AND MEK INHIBITORS IN A PATIENT WITH METASTASIC MELANOMA

被引：0
|
作者：
Alba-Linero, C. [1 ]
Rocha De Lossada, C. [1 ]
Delgado-Fernandez, A. S. [1 ]
Jodar-Marquez, M. [1 ]
Calvo De Mora, M. Rodriguez [1 ]
Berciano-Guerrero, M. A. [2 ]
机构：
[1] Hosp Reg Malaga, Plaza Hosp Civil, Ophthalmol Dept, Malaga 29009, Spain
[2] Hosp Reg Malaga, Oncol Dept, Malaga, Spain
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2019年 / 33卷 / 05期
关键词：
neuroepithelial detachment; metastasic melanoma; BRAF inhibitors; MEK inhibitors; pseudovitelliform;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [1] Safety profile: immunotherapy and Braf/Mek inhibitors in metastasic melanoma
    Casas Hidalgo, I.
    Nieto Gomez, P.
    Rodriguez Delgado, A.
    Alvarez Sanchez, R.
    Rodriguez Gomez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 367 - 368
  • [2] Patient with stage IV melanoma with BRAF mutation - immunotherapy or BRAF and MEK inhibitors?
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (02): : 100 - 103
  • [3] Brugada syndrome induced by BRAF and MEK inhibitors in a melanoma patient
    Nardin, Charlee
    Colas, Morgane
    Badoz, Marc
    Roche-Kubler, Blandine
    Meneveau, Nicolas
    Puzenat, Eve
    Aubin, Francois
    EUROPEAN HEART JOURNAL, 2017, 38 (27) : 2151 - 2151
  • [4] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [5] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [6] BRAF and MEK inhibitors in therapy of advanced melanoma
    Kosela, Hanna
    Switaj, Tomasz
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (05): : 246 - 253
  • [7] Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma
    Sibaud, Vincent
    Baric, Lilian
    Cantagrel, Alain
    Di Palma, Mario
    Ederhy, Stephane
    Paques, Michel
    Perlemuter, Gabriel
    BULLETIN DU CANCER, 2021, 108 (05) : 528 - 543
  • [8] BRAF and MEK Inhibitors Offer Good News in Melanoma
    不详
    CANCER DISCOVERY, 2012, 2 (07)
  • [9] Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanoma
    Rubio-Rivas, Manuel
    Moreira, Catarina
    Marcoval, J.
    AUTOIMMUNITY REVIEWS, 2020, 19 (08)
  • [10] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    K S M Smalley
    K T Flaherty
    British Journal of Cancer, 2009, 100 : 431 - 435
12345